Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus
Anna Kanerva(University of Helsinki), Akseli Hemminki(University of Helsinki), Taco G. Uil(Leiden University Medical Center), Kurt R. Zinn(Michigan State University), Kaori Suzuki(Juntendo University), Zhihong Cao(University of Helsinki), Minghui Wang, Bin Liu(Hormel (United States)), John Lam, Tandra R. Chaudhuri(University of Helsinki), Gerd Bauerschmitz, Ronald D. Alvarez(Breast Cancer Research Foundation), Tanja Hakkarainen(University of Eastern Finland), David T. Curiel(University of Alabama at Birmingham)
Cited by 172
Related Papers
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k
An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism
|Journal of Virology|1998|769
Engineering targeted viral vectors for gene therapy
|Nature Reviews Genetics|2007|678
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487